Noxp20 Activators
Noxp20 Activators are a diverse set of chemical compounds that enhance the functional activity of Noxp20 through modulation of various signaling pathways and post-translational modifications. Forskolin and Isoproterenol operate through the cAMP-PKA axis, where elevated cAMP levels result in PKA activation and subsequent phosphorylation of target proteins that may include Noxp20, thereby enhancing its activity. Similarly, 8-Br-cAMP, a stable cAMP analog, directly activates PKA, leading to the phosphorylation and potential activity enhancement of Noxp20. On the other side of the spectrum, Phorbol 12-myristate 13-acetate (PMA) targets protein kinase C (PKC), whose activation can result in the phosphorylation and consequent activity augmentation of Noxp20. In addition, the polyphenol Resveratrol may promote Noxp20 activity via the deacetylation of proteins through its activation of SIRT1. Sphingosine-1-phosphate (S1P) triggers G-protein coupled receptor pathways, leading to downstream kinase activation that might phosphorylate and thus activate Noxp20. Capsaicin, by stimulating TRPV1, achieves a similar outcome through calcium influx and activation of calcium-dependent kinases that can phosphorylate Noxp20. The calcium ionophore Ionomycin and SERCA inhibitor Thapsigargin both elevate intracellular calcium levels, which could activate Noxp20 through calcium-dependent signaling pathways.
The second set of activators influences Noxp20 indirectly by modulating cellular signaling pathways that intersect with Noxp20's regulatory mechanisms. Anisomycin, a JNK activator, may enhance Noxp20 activity indirectly by influencing gene transcription of proteins that regulate or interact with Noxp20. LY294002, by inhibiting PI3K and modulating the AKT signaling pathway, could prevent inhibitory phosphorylation of Noxp20, leading to its enhanced activity. Epigallocatechin gallate (EGCG) contributes to the activation of Noxp20 by inhibiting kinases that might otherwise phosphorylate Noxp20 at sites that reduce its activity. Through these biochemical actions, these compounds collectively support the heightened functional activity of Noxp20 in cellular processes by targeting specific signaling pathways and modifying the phosphorylation or acetylation status of the protein or its regulatory counterparts.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing the production of cyclic AMP (cAMP), which can lead to the activation of protein kinase A (PKA). PKA can then phosphorylate target proteins, potentially enhancing the activity of Noxp20 by promoting its phosphorylation and activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). PKC activation can lead to the phosphorylation of various substrates, including Noxp20, thereby enhancing Noxp20's functional activity through direct phosphorylation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations. Elevated calcium can activate calcium-dependent kinases, which might phosphorylate and enhance the activity of Noxp20. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol activates sirtuins, particularly SIRT1, which can lead to the deacetylation of proteins and influence cellular signaling pathways. Through the activation of SIRT1, Noxp20 activity could be enhanced due to changes in its acetylation status. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases cAMP levels, thus activating PKA. PKA-mediated phosphorylation can enhance Noxp20 activity as part of downstream signaling effects. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
Sphingosine-1-phosphate (S1P) binds to S1P receptors, leading to the activation of G-protein-coupled receptor signaling pathways. This can result in the activation of downstream kinases that may phosphorylate and enhance Noxp20 activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG is known to inhibit certain protein kinases, thereby potentially reducing negative regulatory phosphorylation of proteins. This reduction may enhance the functional activity of Noxp20 by alleviating inhibitory phosphorylation. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $106.00 $166.00 $289.00 $550.00 $819.00 | 2 | |
8-Br-cAMP is a cAMP analog that activates PKA. PKA then can phosphorylate Noxp20, potentially enhancing its activity through this post-translational modification. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium levels. This can activate calcium-dependent signaling pathways that may enhance Noxp20 activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin is a JNK activator that can lead to the phosphorylation of c-Jun, which may alter transcription of genes encoding proteins that interact with or regulate Noxp20, indirectly enhancing its activity. | ||||||